Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη της θεραπευτικής δράσης της τοσιλιζουμάμπης σε πειραματικό μοντέλο αρθρίτιδας νεαρών επίμυων και η δράση αυτής στην οστική πυκνότητα και τις τενόντιες δομές

Abstract

dc:description

Reduced Bone Mineral Density (BMD) is a prevalent comorbidity in Juvenile Idiopathic Arthritis (JIA). Enthesitis and other tendon abnormalities, such as tenosynovitis, tendinitis and tendon ruptures are, also, common extra-articular manifestations of the disease. The aim of the present study was to investigate the effect of tocilizumab, an antibody that binds the Interleukin-6 (IL-6) Receptor, on inflammation-related bone loss and tendon inflammation in an animal model of JIA. In the present study, 155, male, 6-8-week-old, Wistar rats were used. The Collagen-Induced Arthritis (CIA) model was induced in 120 of them. Rats received tocilizumab intraperitoneally for 8 weeks. Methotrexate, the most widely used Disease-Modifying Antirheumatic Drug in the management of JIA, and infliximab, an antibody against Tumor Necrosis Factor-a (TNF-a) were, also, administered. BMD was evaluated with Micro-Computed Tomography (Micro-CT) and histopathological examination. Tendon damage was, also, assessed histologically. Finally, two pro-inflammatory cytokines, Tumor Necrosis Factor- alpha (TNF-a) and Interleukin-23 (IL-23), were quantified in tendon tissues by ELISA analysis. Tocilizumab had no effect on the bone and tendon morphology of the healthy animals. Regarding arthritic animals, the tocilizumab-treated exhibited a significantly improved trabecular microarchitecture on micro-CT analysis and histological examination. Tendon morphology was, also, improved. Anti-IL-6 treatment led to a significant decrease in TNF-a and IL-23 expression in tendon tissue. Infliximab had a similar effect but to a lower extent. The results of the present study provide evidence that tocilizumab reduces inflammation-related bone loss and suppresses tendon inflammation in a juvenile CIA rat model. These findings offer perspectives for the management of osteoporosis and enthesitis in JIA.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Poutoglidou, Freideriki
  • Πουτογλίδου, Φρειδερίκη

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/50656

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Poutoglidou, Freideriki; Πουτογλίδου, Φρειδερίκη. Μελέτη της θεραπευτικής δράσης της τοσιλιζουμάμπης σε πειραματικό μοντέλο αρθρίτιδας νεαρών επίμυων και η δράση αυτής στην οστική πυκνότητα και τις τενόντιες δομές. Aristotle University Of Thessaloniki (AUTH), 2021. http://hdl.handle.net/10442/hedi/50656